Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027614 |
---|---|
Receipt number | R000031631 |
Scientific Title | Effects of liraglutide and empagliflozin add-on to insulin therapy in patients with type 2 diabetes: a randomized controlled study |
Date of disclosure of the study information | 2017/06/03 |
Last modified on | 2023/04/16 11:17:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/06/02 23:51:50 | ||
2 | Update | 2017/12/20 09:16:52 | Co-sponsor Co-sponsor Institutions |
|
3 | Update | 2017/12/25 10:39:03 | Co-sponsor Institutions |
|
4 | Update | 2018/07/15 06:00:49 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2019/04/23 17:48:38 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2019/05/11 18:08:55 | Interventions/Control_1 |
|
7 | Update | 2019/06/15 16:45:30 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Address Co-sponsor Organization Organization Address Address Tel Institutions |
|
8 | Update | 2019/06/15 16:48:44 | Number of participants that the trial has enrolled |
|
9 | Update | 2019/12/13 06:18:18 | Key secondary outcomes Key secondary outcomes |
|
10 | Update | 2020/01/03 22:42:17 | Co-sponsor Institutions |
|
11 | Update | 2020/06/02 18:09:12 | Recruitment status |
|
12 | Update | 2021/05/22 09:21:42 | Department |
|
13 | Update | 2022/05/10 09:04:42 | Date analysis concluded |
|
14 | Update | 2023/04/16 11:04:06 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
15 | Update | 2023/04/16 11:17:19 | Outcome measures |